APO Research

APO RESEARCH · REPORT

Rescue Inhaler

Selected research

Market Outlook & Growth Opportunities

Global Rescue Inhaler Market Outlook and Growth Opportunities 2026

Market perspective

The global Rescue Inhaler market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rescue Inhaler is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rescue Inhaler is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rescue Inhaler is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rescue Inhaler market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rescue Inhaler market include GSK, Teva, Novartis, Chiesi, AstraZeneca, Organon and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rescue Inhaler market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rescue Inhaler and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rescue Inhaler sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rescue Inhaler market size, projected growth trends, production technologies, key applications, and end-use industries.

Rescue Inhaler Segment by Company

GSK

Teva

Novartis

Chiesi

AstraZeneca

Organon

Boehringer Ingelheim

Rescue Inhaler Segment by Type

Levalbuterol

Albuterol

Pirbuterol

Other

Rescue Inhaler Segment by Application

COPD

Asthma

Other

Rescue Inhaler Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rescue Inhaler status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rescue Inhaler market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rescue Inhaler significant trends, drivers, influence factors in global and regions.

6. To analyze Rescue Inhaler competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rescue Inhaler market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rescue Inhaler and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rescue Inhaler.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rescue Inhaler market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rescue Inhaler industry.

Chapter 3: Detailed analysis of Rescue Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rescue Inhaler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rescue Inhaler in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rescue Inhaler Industry Trends Table 2. Rescue Inhaler Industry Drivers Table 3. Rescue Inhaler Industry Opportunities and Challenges Table 4. Rescue Inhaler Industry Restraints Table 5. Global Rescue Inhaler Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rescue Inhaler Revenue Share by Company (2021-2026) Table 7. Global Rescue Inhaler Sales Volume by Company (k units) & (2021-2026) Table 8. Global Rescue Inhaler Sales Volume Share by Company (2021-2026) Table 9. Global Rescue Inhaler Average Price (US$/unit) of Company (2021-2026) Table 10. Global Rescue Inhaler Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rescue Inhaler Key Company Manufacturing Base & Headquarters Table 12. Global Rescue Inhaler Company, Product Type & Application Table 13. Global Rescue Inhaler Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rescue Inhaler by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Levalbuterol Table 18. Significant Companies of Albuterol Table 19. Significant Companies of Pirbuterol Table 20. Significant Companies of Other Table 21. Global Rescue Inhaler Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Rescue Inhaler Sales Volume by Type (2021-2026) & (k units) Table 23. Global Rescue Inhaler Sales Volume by Type (2027-2032) & (k units) Table 24. Global Rescue Inhaler Sales Volume Share by Type (2021-2026) Table 25. Global Rescue Inhaler Sales Volume Share by Type (2027-2032) Table 26. Global Rescue Inhaler Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Rescue Inhaler Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Rescue Inhaler Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Rescue Inhaler Sales Value Share by Type (2021-2026) Table 30. Global Rescue Inhaler Sales Value Share by Type (2027-2032) Table 31. Significant Companies of COPD Table 32. Significant Companies of Asthma Table 33. Significant Companies of Other Table 34. Global Rescue Inhaler Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Rescue Inhaler Sales Volume by Application (2021-2026) & (k units) Table 36. Global Rescue Inhaler Sales Volume by Application (2027-2032) & (k units) Table 37. Global Rescue Inhaler Sales Volume Share by Application (2021-2026) Table 38. Global Rescue Inhaler Sales Volume Share by Application (2027-2032) Table 39. Global Rescue Inhaler Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Rescue Inhaler Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Rescue Inhaler Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Rescue Inhaler Sales Value Share by Application (2021-2026) Table 43. Global Rescue Inhaler Sales Value Share by Application (2027-2032) Table 44. Global Rescue Inhaler Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Rescue Inhaler Sales by Region (2021-2026) & (k units) Table 46. Global Rescue Inhaler Sales Market Share by Region (2021-2026) Table 47. Global Rescue Inhaler Sales by Region (2027-2032) & (k units) Table 48. Global Rescue Inhaler Sales Market Share by Region (2027-2032) Table 49. Global Rescue Inhaler Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Rescue Inhaler Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Rescue Inhaler Sales Value Share by Region (2021-2026) Table 52. Global Rescue Inhaler Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Rescue Inhaler Sales Value Share by Region (2027-2032) Table 54. Global Rescue Inhaler Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Rescue Inhaler Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Rescue Inhaler Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Rescue Inhaler Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Rescue Inhaler Sales by Country (2021-2026) & (k units) Table 59. Global Rescue Inhaler Sales Market Share by Country (2021-2026) Table 60. Global Rescue Inhaler Sales by Country (2027-2032) & (k units) Table 61. Global Rescue Inhaler Sales Market Share by Country (2027-2032) Table 62. Global Rescue Inhaler Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Rescue Inhaler Sales Value Market Share by Country (2021-2026) Table 64. Global Rescue Inhaler Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Rescue Inhaler Sales Value Market Share by Country (2027-2032) Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Rescue Inhaler Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. GSK Rescue Inhaler Product Portfolio Table 70. GSK Recent Development Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Rescue Inhaler Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Rescue Inhaler Product Portfolio Table 75. Teva Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Rescue Inhaler Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis Rescue Inhaler Product Portfolio Table 80. Novartis Recent Development Table 81. Chiesi Company Information Table 82. Chiesi Business Overview Table 83. Chiesi Rescue Inhaler Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Chiesi Rescue Inhaler Product Portfolio Table 85. Chiesi Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Rescue Inhaler Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. AstraZeneca Rescue Inhaler Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Organon Company Information Table 92. Organon Business Overview Table 93. Organon Rescue Inhaler Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Organon Rescue Inhaler Product Portfolio Table 95. Organon Recent Development Table 96. Boehringer Ingelheim Company Information Table 97. Boehringer Ingelheim Business Overview Table 98. Boehringer Ingelheim Rescue Inhaler Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Boehringer Ingelheim Rescue Inhaler Product Portfolio Table 100. Boehringer Ingelheim Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Rescue Inhaler Distributors List Table 104. Rescue Inhaler Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Rescue Inhaler Product Image Figure 2. Global Rescue Inhaler Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rescue Inhaler Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rescue Inhaler Sales (2021-2032) & (k units) Figure 5. Global Rescue Inhaler Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Rescue Inhaler Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Levalbuterol Image Figure 10. Albuterol Image Figure 11. Pirbuterol Image Figure 12. Other Image Figure 13. Global Rescue Inhaler Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Rescue Inhaler Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Rescue Inhaler Sales Volume Share by Type (2021-2032) Figure 16. Global Rescue Inhaler Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Rescue Inhaler Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Rescue Inhaler Sales Value Share by Type (2021-2032) Figure 19. COPD Image Figure 20. Asthma Image Figure 21. Other Image Figure 22. Global Rescue Inhaler Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Rescue Inhaler Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Rescue Inhaler Sales Volume Share by Application (2021-2032) Figure 25. Global Rescue Inhaler Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Rescue Inhaler Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Rescue Inhaler Sales Value Share by Application (2021-2032) Figure 28. Global Rescue Inhaler Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Rescue Inhaler Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Rescue Inhaler Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Rescue Inhaler Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Rescue Inhaler Sales Value (2021-2032) & (US$ Million) Figure 33. North America Rescue Inhaler Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Rescue Inhaler Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Rescue Inhaler Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Rescue Inhaler Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Rescue Inhaler Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Rescue Inhaler Sales Value (2021-2032) & (US$ Million) Figure 39. South America Rescue Inhaler Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Rescue Inhaler Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Rescue Inhaler Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Rescue Inhaler Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Rescue Inhaler Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Rescue Inhaler Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Rescue Inhaler Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Rescue Inhaler Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Levalbuterol
  • Albuterol
  • Pirbuterol
  • Other
Applications
  • COPD
  • Asthma
  • Other
Companies covered
  • GSK
  • Teva
  • Novartis
  • Chiesi
  • AstraZeneca
  • Organon
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rescue Inhaler Sales Value (2021-2032)
  4. 1.2.2 Global Rescue Inhaler Sales Volume (2021-2032)
  5. 1.2.3 Global Rescue Inhaler Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rescue Inhaler Market Dynamics
  1. 2.1 Rescue Inhaler Industry Trends
  2. 2.2 Rescue Inhaler Industry Drivers
  3. 2.3 Rescue Inhaler Industry Opportunities and Challenges
  4. 2.4 Rescue Inhaler Industry Restraints
3 Rescue Inhaler Market by Company
  1. 3.1 Global Rescue Inhaler Company Revenue Ranking in 2025
  2. 3.2 Global Rescue Inhaler Revenue by Company (2021-2026)
  3. 3.3 Global Rescue Inhaler Sales Volume by Company (2021-2026)
  4. 3.4 Global Rescue Inhaler Average Price by Company (2021-2026)
  5. 3.5 Global Rescue Inhaler Company Ranking (2024-2026)
  6. 3.6 Global Rescue Inhaler Company Manufacturing Base and Headquarters
  7. 3.7 Global Rescue Inhaler Company Product Type and Application
  8. 3.8 Global Rescue Inhaler Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rescue Inhaler Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rescue Inhaler Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rescue Inhaler Market by Type
  1. 4.1 Rescue Inhaler Type Introduction
  2. 4.1.1 Levalbuterol
  3. 4.1.2 Albuterol
  4. 4.1.3 Pirbuterol
  5. 4.1.4 Other
  6. 4.2 Global Rescue Inhaler Sales Volume by Type
  7. 4.2.1 Global Rescue Inhaler Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Rescue Inhaler Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Rescue Inhaler Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Rescue Inhaler Sales Value by Type
  11. 4.3.1 Global Rescue Inhaler Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Rescue Inhaler Sales Value by Type (2021-2032)
  13. 4.3.3 Global Rescue Inhaler Sales Value Share by Type (2021-2032)
5 Rescue Inhaler Market by Application
  1. 5.1 Rescue Inhaler Application Introduction
  2. 5.1.1 COPD
  3. 5.1.2 Asthma
  4. 5.1.3 Other
  5. 5.2 Global Rescue Inhaler Sales Volume by Application
  6. 5.2.1 Global Rescue Inhaler Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rescue Inhaler Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Rescue Inhaler Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Rescue Inhaler Sales Value by Application
  10. 5.3.1 Global Rescue Inhaler Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rescue Inhaler Sales Value by Application (2021-2032)
  12. 5.3.3 Global Rescue Inhaler Sales Value Share by Application (2021-2032)
6 Rescue Inhaler Regional Sales and Value Analysis
  1. 6.1 Global Rescue Inhaler Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rescue Inhaler Sales by Region (2021-2032)
  3. 6.2.1 Global Rescue Inhaler Sales by Region: 2021-2026
  4. 6.2.2 Global Rescue Inhaler Sales by Region (2027-2032)
  5. 6.3 Global Rescue Inhaler Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rescue Inhaler Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rescue Inhaler Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rescue Inhaler Sales Value by Region (2027-2032)
  9. 6.5 Global Rescue Inhaler Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rescue Inhaler Sales Value (2021-2032)
  12. 6.6.2 North America Rescue Inhaler Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rescue Inhaler Sales Value (2021-2032)
  15. 6.7.2 Europe Rescue Inhaler Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rescue Inhaler Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rescue Inhaler Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rescue Inhaler Sales Value (2021-2032)
  21. 6.9.2 South America Rescue Inhaler Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rescue Inhaler Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rescue Inhaler Sales Value Share by Country, 2025 VS 2032
7 Rescue Inhaler Country-level Sales and Value Analysis
  1. 7.1 Global Rescue Inhaler Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rescue Inhaler Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rescue Inhaler Sales by Country (2021-2032)
  4. 7.3.1 Global Rescue Inhaler Sales by Country (2021-2026)
  5. 7.3.2 Global Rescue Inhaler Sales by Country (2027-2032)
  6. 7.4 Global Rescue Inhaler Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rescue Inhaler Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rescue Inhaler Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rescue Inhaler Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rescue Inhaler Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rescue Inhaler Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rescue Inhaler Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rescue Inhaler Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rescue Inhaler Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rescue Inhaler Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rescue Inhaler Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rescue Inhaler Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rescue Inhaler Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rescue Inhaler Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rescue Inhaler Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rescue Inhaler Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rescue Inhaler Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rescue Inhaler Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rescue Inhaler Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rescue Inhaler Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rescue Inhaler Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rescue Inhaler Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rescue Inhaler Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rescue Inhaler Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rescue Inhaler Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rescue Inhaler Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rescue Inhaler Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rescue Inhaler Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rescue Inhaler Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rescue Inhaler Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rescue Inhaler Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rescue Inhaler Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rescue Inhaler Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Rescue Inhaler Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Rescue Inhaler Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Rescue Inhaler Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Rescue Inhaler Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Rescue Inhaler Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Rescue Inhaler Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Chiesi
  20. 8.4.1 Chiesi Company Information
  21. 8.4.2 Chiesi Business Overview
  22. 8.4.3 Chiesi Rescue Inhaler Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chiesi Rescue Inhaler Product Portfolio
  24. 8.4.5 Chiesi Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Rescue Inhaler Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Rescue Inhaler Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Organon
  32. 8.6.1 Organon Company Information
  33. 8.6.2 Organon Business Overview
  34. 8.6.3 Organon Rescue Inhaler Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Organon Rescue Inhaler Product Portfolio
  36. 8.6.5 Organon Recent Developments
  37. 8.7 Boehringer Ingelheim
  38. 8.7.1 Boehringer Ingelheim Company Information
  39. 8.7.2 Boehringer Ingelheim Business Overview
  40. 8.7.3 Boehringer Ingelheim Rescue Inhaler Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Boehringer Ingelheim Rescue Inhaler Product Portfolio
  42. 8.7.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rescue Inhaler Value Chain Analysis
  2. 9.1.1 Rescue Inhaler Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rescue Inhaler Sales Mode & Process
  6. 9.2 Rescue Inhaler Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rescue Inhaler Distributors
  9. 9.2.3 Rescue Inhaler Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research